Most Read News


Prosecution soon to reveal final rebate investigation result, enlarging intense in pharmaceutical and distribution fields

The Eastern Branch of Busan District Public Prosecutors’ Office, which has strongly investigated illegal rebates, has brought tension to pharmaceutical companies and pharmaceutical distribution companies for the inves...

How to evaluate and report safety for drug clinical trials?

A guideline for safety evaluation and report was prepared for pharmaceutical companies to use at drug clinical trials. Pharmaceutical companies, clients for clinical trial, must have a person taking in charge of moni...

Novo Nordisk acquires Korean approval of ‘Saxenda,’ GLP-1 analogue obesity treatment

Novo Nordisk Korea(President Rana Azfar Zafar) announced that Saxenda(generic name: liraglutide), its new obesity therapy, was approved from the Ministry of Food and Drug Safety on the 21st. Saxenda is the world’s ob...

Congested development of generic drugs with rapid decrease in bioequivalently-tested products

It was observed there were 329 pharmaceutical products newly approved with bioequivalence test this year, decreased by a half compared to the same period of the last year. According to the Ministry of Food and Drug S...

Approvals for ‘Tamifly’ generics about to pour out for bioequivalence tests

Approvals for generics of ‘Tamiflu,’ a influenza virus treatment whose patent is expiring on the 22nd of August, are pouring out. According to the Ministry of Food and Drug Safety(MFDS) on the 25th, 15 generic drugs ...

It is time to change 3-shipment-a-day custom in pharma distribution industry

In the fierce competition among pharmaceutical distribution companies, it was criticized it was a time to change the custom of delivering 3 times a day. According to the industry concerned, the 3-shipment-a-day servi...

Green Cross manufactures and Roche Korea imports biologics the most

Green Cross, a blood preparation and vaccine company, was ranked the top in production with s KRW 506.8 billion manufacturing performance of biologics last year. Moreover, a foreign company which imported biologics th...

Minister Neung-Hoo Park promised to resolve national responsibility for dementia, uninsured benefits and social vaccines

Minister Neung-Hoo Park of Health and Welfare(MOHW) suggested a blueprint of the MOHW’s healthcare policy based on the government’s 5-year road map. When it comes to the healthcare field, he emphasized publicity, mak...

LG Chem acquires approval of diabetes & dyslipidemia complex for first time in Korea

LG Chem announced ‘Zemiro,’ a complex drug developed for 5 years as a treatment of diabetes and dyslipidemia, was approved to be commercialized in Korea from the Ministry of Food and Drug Safety. It is the first time ...

MOHW, “It’s hard to judge if lecture and consulting fees are rebates”

In the circumstance where indirect illegal rebates on healthcare providers to support symposiums have recently become an issue, the Ministry of Health and Welfare(MOHW) are also worrying about a yardstick for judgment...

Hanmi creates lineup with Amosartan family, challenging annul KRW 100 million sales

Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) acquired approvals for 2 products of 2-substance combination drug containing the substance of Amosartan, the top sales product. Hanmi is planning to continue the Amosartan...

Rapid decrease of Gaviscon sales congests second movers

As sales of ‘Gaviscon,’ an Oxy Reckitt Benckiser’s antipeptic ulcer drug, have rapidly dropped after the humidifier cleaner crisis, products containing alginic acid as a main substance are known to have poor performan...

Celltrion’s ‘Truxima’ reaches 30% market share in Europe only in 3 months of launch

‘Truxima,’ an antibody biosimilar launched by Celltrion Healthcare for the 2nd time in Europe, seems to rapidly grow in the European market. Celltrion Healthcare announced on the 1st that ‘Truxima,’ an antibody biosi...

Financial Gain & Expenditure Report pressures small & medium pharmas

If a pharmaceutical company(or medical device manufacturer) provides financial benefits to healthcare providers, it must write and store a report for them, and if Minister of Health and Welfare(MOHW) asks for this, th...

Pharma distribution industry’s concerns over minimum wages increase

Pharmaceutical distribution companies are seeking for measures in response to various unfavorable factors, such as reduction of distribution margins for specific products, downscale of client distributors from pharmac...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.